Patents/Inventors

Yibin Zeng

Foster City, CAUS15 patents

15 Patents

US126114042026
Aza-aryl 1h-pyrazol-1-yl Benzene Sulfonamides
CHEMOCENTRYX, Inc.
0 cites
US125333542026
Triaryl Compounds for Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US124973832025
Heteroaryl-biphenyl Amides for the Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US124483732025
Azetidinyl-acetamides as CXCR7 Inhibitors
AMGEN Inc.
0 cites
US123714332025
Heteroaryl-biphenyl Amines for the Treatment of PD-L1 Diseases
AMGEN Inc.
0 cites
US122686752025
Diaryl Substituted 6,5-fused Ring Compounds as C5ar Inhibitors
CHEMOCENTRYX, Inc.
0 cites
US120544842024
Substituted Tetrahydropyrans as CCR2 Modulators
CHEMOCENTRYX, Inc.
0 cites
US118833912024
Compositions and Methods for Treating Inflammatory Bowel Disease Using CCR9 Inhibitor and Anti-il-23 Blocking Antibodies
CHEMOCENTRYX, Inc.
0 cites
US118664292024
Heteroaryl-biphenyl Amines for the Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US118344522023
CXCR7 Antagonists
CHEMOCENTRYX, Inc.
0 cites
US118076092023
Deuterated Compounds as Immunomodulators
CHEMOCENTRYX, Inc.
0 cites
US117730912023
6-5 Fused Rings as C5a Inhibitors
CHEMOCENTRYX, Inc.
0 cites
US117133072023
Heteroaryl-biphenyl Amides for the Treatment of PD-L1 Diseases
CHEMOCENTRYX, Inc.
0 cites
US116083362023
Prodrugs of Fused-bicyclic C5ar Antagonists
CHEMOCENTRYX, Inc.
0 cites
US116033562023
Amorphous Form of a Complement Component C5a Receptor
CHEMOCENTRYX, Inc.
0 cites